Skip to content

Women With Asymptomatic Endometrial Hyperplasia

Women With Asymptomatic Endometrial Hyperplasia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02100137
Acronym
FAME-ENDO
Enrollment
1000
Registered
2014-03-31
Start date
2006-09-30
Completion date
2012-07-31
Last updated
2014-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Hyperplasia

Brief summary

The purpose of this study is to evaluate the clinical meaning of an endometrial hyperplasia diagnosed using a vaginal ultrasound during routine gynecological examination.

Interventions

vaginal ultrasound performed at a routine gyn examination

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* asymptomatic women with endometrial hyperplasia diagnosed using a vaginal ultrasound

Exclusion criteria

* postmenopausal bleeding

Design outcomes

Primary

MeasureTime frame
Number of invasive endometrial cancersParticipants will be followed for the duration of hospital and until the results of the final histology from the endometrial biopsy are completed, for an expected average of 10 days

Secondary

MeasureTime frame
Number of women with atypical endometrial hyperplasiaParticipants will be followed for the duration of hospital and until the results of the final histology from the endometrial biopsy are completed, for an expected average of 10 days

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026